A cross-sectional study on the impact of NLRP3 and FGF23 levels on atherosclerotic cardiovascular disease in elderly diabetic patients
Advances in Interventional Cardiology · 2026 · 22 (1) · 41-47
DOI: 10.5114/aic.2026.160068 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Advances in Interventional Cardiology, 2026. Verfasst von Bin Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Xianning Central Hospital, the First Affiliated Hospital of Hubei University of Science and Technology, Xianning, …. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Xianning Central Hospital, the First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei Province, China.
- Department of Blood Transfusion, Xianning Central Hospital, the First Affiliated Hospital of Hubei University of Science and Technology, Xianning, Hubei Province, China.
Zitieren
APA
Luo, B., Zhou, R., & Ye, B. (2026). A cross-sectional study on the impact of NLRP3 and FGF23 levels on atherosclerotic cardiovascular disease in elderly diabetic patients. Advances in Interventional Cardiology, 22(1), 41-47. https://doi.org/10.5114/aic.2026.160068
Vancouver
Luo B, Zhou R, Ye B. A cross-sectional study on the impact of NLRP3 and FGF23 levels on atherosclerotic cardiovascular disease in elderly diabetic patients. Advances in Interventional Cardiology. 2026;22(1):41-47. doi:10.5114/aic.2026.160068
BibTeX
@article{Luo2026,
author = {Luo, Bin and Zhou, Ruifen and Ye, Bining},
title = {A cross-sectional study on the impact of NLRP3 and FGF23 levels on atherosclerotic cardiovascular disease in elderly diabetic patients},
journal = {Advances in Interventional Cardiology},
year = {2026},
volume = {22},
number = {1},
pages = {41--47},
doi = {10.5114/aic.2026.160068}
}
EUVIMED